Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research

References

• UK medicines regulator gives approval for first UK COVID-19 vaccine—GOV.UK [Internet]. [cited 2021 Jan 31]. Available from: https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine.
   Google Scholar
• Ledford H, Cyranoski D, Van Noorden R. The UK has approved a COVID vaccine—here’s what scientists now want to know. Nature. NLM (Medline); 2020. p. 205–6.
   Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Health Policy. 2021.
   Google Scholar
• WHO—COVID19 Vaccine Tracker [Internet]. [cited 2021 Dec 13]. Available from: https://covid19.trackvaccines.org/agency/who/.
   Google Scholar
• Abbas N, Hasan SS, Curley L, Babar Z-U-D. Access to medicines—a systematic review of the literature. Res Social Adm Pharm. 2020;16.
   Google Scholar
• Vagnoni C, Barber S. Regulatory approval of COVID-19 vaccines in the UK [Internet]. [cited 2021 Jan 31]. Available from: https://post.parliament.uk/regulatory-approval-of-covid-19-vaccines-in-the-uk/.
   Google Scholar
• The mechanics of medicines regulation—shining a spotlight on the MHRA vaccine approval decision | Brodies LLP [Internet]. [cited 2021 Dec 13]. Available from: https://brodies.com/insights/healthcare-and-life-sciences/the-mechanics-of-medicines-regulation-shining-a-spotlight-on-the-mhra-vaccine-approval-decision/.
   Google Scholar
• Public Assessment Report Authorisation for Temporary Supply COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA) concentrate for solution for injection.
   Google Scholar
• Mahase E. Vaccinating the UK: how the covid vaccine was approved, and other questions answered. The BMJ. BMJ Publishing Group; 2020.
   Google Scholar
• Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done? Health Policy. 2021;125:553–567.
   PubMed Web of Science ®Google Scholar
• The mechanics of medicines regulation—shining a spotlight on the MHRA vaccine approval decision | Brodies LLP [Internet]. [cited 2021 Jan 31]. Available from: https://brodies.com/insights/healthcare-and-life-sciences/the-mechanics-of-medicines-regulation-shining-a-spotlight-on-the-mhra-vaccine-approval-decision/.
   Google Scholar
• Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech—GOV.UK [Internet]. [cited 2021 Dec 13]. Available from: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-of-product-characteristics-for-covid-19-vaccine-pfizerbiontech.
   Google Scholar
• EMA recommends first COVID-19 vaccine for authorisation in the EU | European Medicines Agency [Internet]. [cited 2021 Dec 13]. Available from: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu.
   Google Scholar
• CHMP. Committee for Medicinal Products for Human Use (CHMP) Assessment report Comirnaty Common name: COVID-19 mRNA vaccine (nucleoside-modified).
   Google Scholar
• Conditional marketing authorisation | European Medicines Agency [Internet]. [cited 2021 Jan 31]. Available from: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/conditional-marketing-authorisation.
   Google Scholar
• CHMP. Committee for Medicinal Products for Human Use (CHMP) Assessment report on the annual renewal of the conditional marketing authorisation. [cited 2021 Dec 13]; Available from: www.ema.europa.eu/contact.
   Google Scholar
• Emergency Use Authorization for Vaccines Explained | FDA [Internet]. [cited 2021 Dec 13]. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained.
   Google Scholar
• Administration D. Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum Identifying Information Application Type EUA (Event-driven EUA request) Application Number 27034 Sponsor Pfizer, Inc., on behalf of Pfizer and BioNTech Submission Date. 2020.
   Google Scholar
• How key decisions slowed FDA’s review of Covid-19 vaccine [Internet]. [cited 2021 Jan 31]. Available from: https://www.statnews.com/2020/12/04/how-key-decisions-slowed-fdas-review-of-covid-19-vaccine-but-also-gave-it-important-data/.
   Google Scholar
• FDA Approves First COVID-19 Vaccine | FDA [Internet]. [cited 2021 Dec 13]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
   Google Scholar
• Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms? | McKinsey [Internet]. [cited 2021 Dec 16]. Available from: https://www.mckinsey.com/industries/life-sciences/our-insights/fast-forward-will-the-speed-of-covid-19-vaccine-development-reset-industry-norms.
   Google Scholar
• Emergency Use Authorization and FDA approval, vaccine fact check | wusa9.com [Internet]. [cited 2021 Dec 13]. Available from: https://www.wusa9.com/article/news/verify/emergency-use-authorization-fda-approval-vaccines-fact-check/65-7391e595-cee0-4a00-8468-194a6e0a21a4.
   Google Scholar
• Merchant HA. CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals. J Pharm Policy Pract. 2021;14:1–2. https://doi.org/10.1186/s40545-021-00315-w
   PubMedGoogle Scholar